Article info
PDFSection 4: Clinical Pharmacy Services
4CPS-108 A review of infliximab biosimilar to biosimilar switch: Remsima to Flixabi
Citation
4CPS-108 A review of infliximab biosimilar to biosimilar switch: Remsima to Flixabi
Publication history
- First published March 24, 2020.
Online issue publication
August 05, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.